Inside Indiana Business: New IBRI Study 'Essence of Big Data'

1/13/2017

Inside Indiana Business reports:

"The Indiana Biosciences Research Institute in Indianapolis is bringing together several big industry names for a major study on how type 2 diabetes varies in different patients. Chief Executive Officer David Broecker says the "first-of-its-kind" partnership involves Eli Lilly and Co. (NYSE: LLY), Roche Diagnostics Corp., the Regenstrief Institute and Indiana University School of Medicine. He says the collaboration will give researchers access to information on more than 800,000 people with type 2 diabetes throughout Indiana." Read more.

2019 Annual Report cover

The IBRI 2019 Annual Report is now available. The report theme is “Catalyze, Complement, Connect,” which correlates with the IBRI's goals to seek solutions for health problems, enhance the Indiana life sciences ecosystem, and expedite solutions for the most pressing health issues.